Know Cancer

or
forgot password

Protocol For A Research Database For Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries


N/A
N/A
N/A
Open (Enrolling)
Both
Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Solid Tumors, Blood Cancers

Thank you

Trial Information

Protocol For A Research Database For Hematopoietic Stem Cell Transplantation and Marrow Toxic Injuries

Inclusion Criteria


Eligibility to Participate in the Research Database

Recipient Eligibility Criteria:

- Any recipient of an unrelated or related donor or autologous HSC transplant in a
CIBMTR center is eligible to participate in the Research Database. This includes
adults with and without decision making capacity, and children.

Individual with Marrow Toxic Injury Eligibility Criteria:

- Any individual who is treated for a marrow toxic injury at a center participating in
the NMDP's Radiation Injury Transplant Network (RITN) is eligible to participate in
the Research Database. This includes adults with and without decision making
capacity, and children. Eligible individuals may have received supportive care only,
growth factor support, HSC transplant or other appropriate medical treatment for
marrow toxic injury. Treatments applied are at the discretion of the care facility,
and are not determined by the NMDP or CIBMTR.

Unrelated Donor Eligibility Criteria:

- All donors registered on the NMDP Registry who have been requested to donate a
product for a recipient are eligible to participate in the Research Database.

- All maternal cord blood donors are enrolled in the NMDP Cord Blood Bank
Investigational New Drug (IND) protocol, and sign an informed consent document
specific to that protocol. Data collected as part of the Cord Blood Bank protocol are
included in the Research Database.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

A Comprehensive Source of Observational Data to assess Stem Cell Transplant

Outcome Description:

A primary outcome is to have a comprehensive source of stem cell transplant data that can be used to assess topics such as: Recipient Recover time How recovery after transplant can be improved Long term outcomes after transplantation How well donors recover from collection procedure

Outcome Time Frame:

Anually - on average

Safety Issue:

No

Principal Investigator

Douglas Rizzo, M.D.,M.S

Investigator Role:

Principal Investigator

Investigator Affiliation:

Center for International Blood and Marrow Transplant Research

Authority:

United States: Institutional Review Board

Study ID:

NMDP IRB-1999-0021

NCT ID:

NCT01166009

Start Date:

July 2002

Completion Date:

Related Keywords:

  • Autologous Stem Cell Transplantation
  • Allogeneic Stem Cell Transplantation
  • Solid Tumors
  • Blood Cancers
  • Data Collection
  • CIBMTR
  • NMDP
  • Stem Cell Transplantation
  • Hematologic Neoplasms

Name

Location

Center for International Blood and Marrow Transplant ResearchMinneapolis, Minnesota  55413